Showing results 1 to 7 of 7
Title | Author(s) | Issue Date | |
---|---|---|---|
A Novel Splice Variant to NCOR2 as Biomarker for Tamoxifen Resistant Breast Cancer Proceeding/Conference:WIN 2017 Symposium | 2017 | ||
BQ323636.1, a Novel Splice Variant to NCOR2, as a Predictor for Tamoxifen Resistant Breast Cancer Journal:Clinical Cancer Research | 2018 | ||
2016 | |||
DPYD genotype-guided dose individualisation of fluoropyrimidine therapy: who and how? Journal:The Lancet Oncology | 2019 | ||
KPNA1 regulates nuclear import of NCOR2 splice variant BQ323636.1 to confer tamoxifen resistance in breast cancer Journal:Clinical and Translational Medicine | 2021 | ||
2019 | |||
Repurposing hyperpolarization‐activated cyclic nucleotide‐gated channels as a novel therapy for breast cancer Journal:Clinical and Translational Medicine | 2021 |